Living with Diabetes? Check out our site for you

Healthcare professional? This is your dedicated site.




A patient’s HbA1C score is integral for diabetes control but it is not the only indication of being healthy. Wide fluctuations in blood sugar levels may show that the HbA1c goal is achieved because the average is good, but does not capture many important variables, including time spent high or low.

Time in range, however, can provide additional insights beyond A1C including visibility of your high and low glucose levels throughout the day.

Insulin Pump Therapy, also called continuous subcutaneous insulin infusion (CSII), mimics the physiologic function of a normal pancreas, providing fewer fluctuations in blood sugar levels, more flexibility, less hypoglycaemia and better control, especially overnight. This therapy provides more complete information, allowing your patients to make confident decisions.

Want to improve Time in Range?

We have a number of products that will help you and your patients achieve better control of their diabetes.

The MiniMed® 770G system is an insulin delivery system designed to help people on intensive insulin therapy achieve better control and greater freedom3.

The system consists of an insulin pump with a hybrid closed loop algorithm, a continuous glucose monitor,diabetes care management software, a blood glucose monitor and MiniMed® infusion sets.


Programmed Insulin and 'On-Demand' Insulin

  • Basal Rate: This is a programmed insulin rate made up of small amounts of insulin delivered continuously, mimicking the basal insulin produced by the pancreas. You can determine the programmed rate, based on your patient’s needs. This basal rate delivery can also be customised according to specific daily needs and can be suspended or altered for a definite time frame - this is not possible with long acting insulin injections.
  • Bolus Dose: This is the additional insulin that can be delivered ‘on-demand’ to match the meal plan or to correct high blood glucose. Insulin Pumps have Bolus calculators that help the patients calculate their Bolus amount based on settings that are pre-determined by you.
  • Patients are four times more likely to consistently achieve their target HbA1c on Insulin Pump Therapy than with injections16
  • Insulin Pump Therapy uses only rapid-acting insulin, which is absorbed more predictably and precisely than multiple daily injections
  • For patients eligible and registered with the National Diabetes Services Scheme (NDSS), monthly insulin pump consumables costs will be around AU$25-30.

What are the benefits of Insulin Pump Therapy and how can it help your patients to achieve better glucose control?

Insulin Pump Therapy

With its ability to adjust insulin delivery, the MiniMed® 770G Insulin Pump can also provide the following advantages over Multipal Daily Injections:

  • Easier dosing: calculating insulin requirements can be a complex task, with many different aspects to be considered. The MiniMed® 770G has a built-in Bolus Wizard™ for accurate dosing. It works by taking into account any insulin already in the body, the current glucose levels, carbohydrate intake and personal insulin settings.
  • More flexibility: the MiniMed® 770G can be instantly adjusted to allow for exercise, illness or to deliver small boluses to cover meals and snacks. This is easily done with a touch of a button. There is even a temporary basal rate option to proportionally reduce or increase the basal insulin rate.
  • Staying connected: the MiniMed® 770G can connect up to 5 Care Partners who can remotely track the high and lows through a mobile app, helping families feel more confident throughout the day.
  • Greater convenience: the MiniMed® 770G offers the additional convenience of a wirelessly connected blood glucose meter. This meter automatically sends blood glucose values to the pump, allowing more accurate Bolus Wizard™ calculations and to deliver insulin boluses discreetly.

Insulin Pump Therapy as a system^: how does the insulin get into the patient’s body?

The insulin pump consists of:

  1. A compartment that holds a reservoir
  2. The reservoir (which is filled with insulin)
  3. From the reservoir, insulin is infused into the patient’s body through an infusion set
  4. The infusion set is inserted into the body and is infused through a tiny flexible tube called a cannula that sits just underneath the skin.

Insulin Pump

A durable electronic device that has:

  • Buttons to program insulin and navigate through the menu
  • An LCD colour screen to show the programming
  • A reservoir compartment


This is a plastic cartridge that holds the insulin and is locked into the Insulin Pump. It comes with a transfer guard, the blue piece at the top that is removed before inserting the reservoir into the pump. This assists with pulling the insulin from a vial into the reservoir.

Infusion Set

An infusion set includes a thin tube that goes from the reservoir to the infusion site on the patient’s body. The cannula is inserted with a small needle that is removed after it is in place15. It goes into sites (areas) on the patient’s body, similar to where they would usually inject insulin. The infusion set is changed every two to three days.​

Is Insulin Pump Therapy right for your patient?

Insulin Pump Therapy is beneficial for use by children, adolescents and adults who:

  • Have poorly controlled HbA1c
  • Want to improve their HbA1c
  • Want a more flexible therapy
  • Have onset or concerns of long-term complications
  • Experience dawn phenomenon
  • Have needle phobia
  • Have gastroparesis
  • Have more than two severe hypoglycaemic events in the last 6 months
  • Have hypoglycaemia unawareness
  • Have an inconsistent schedule
  • Are pregnant or planning to conceive
  • Problems with glycaemic variability
  • Are not having their needs met by MDI

2. The patient is a member of the Medtronic Patient Ambassador Program. This patient testimonial relates an account of an individual’s response to the treatment. The account is genuine, typical and documented. However, the individual’s response does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. The response other persons have to the treatment could be different. Responses to the treatment discussed can and do vary and are specific to the individual patient. Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results and other important medical information that pertains to the therapy or products discussed.

10. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in Type 1 diabetes. Diabetes Care.1996;19:324-327

11. U.S. Enlite™ Clinical Study Customer Satisfaction Survey. Data on File. Medtronic MiniMed, Inc., Northridge, CA

12. Bergenstal RM, Tamborlane WV, Ahmann A, et al. The STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in Insulin Dependent Diabetes. N Engl J Med. 2010;363(4):311-320.

13. Garg S, Brazg RL, Bailey TS , et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Tech Ther. 2012;14(3):205-209.

14. Battelino T et al. The SWITCH Study. Pediatric Diabetes 2011 Diabetologia DOI 10.1007/s00125-012-2708-9 Epub ahead of print and Aspire In-Home

15. Please note, the Sure T-infusion set is a steel cannula and therefore does not have a removable introducer needle.

16. Automated insulin delivery is made possible through combining Medtronic insulin pump and continuous glucose monitoring technology.

^Components sold separately.